January 7, 2021 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

MilliporeSigma Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics

Adds to MilliporeSigma’s lipid manufacturing expertise, providing an integrated offering across mRNA value chain AmpTec’s differentiated polymerase chain reaction (PCR)-based technology has shown to have advantages over other technologies for mRNA manufacturing Diagnostics business focused on producing customized long RNAs and DNAs for in vitro diagnostics, complements existing MilliporeSigma portfolio Burlington, Massachusetts, January 7, 2020 — MilliporeSigma today... Read more

October 18, 2019 PR/Corporate

Merck KGaA, Darmstadt, Germany, Launches Seed Fund for Startups in China

Merck KGaA, Darmstadt, Germany, today announced an RMB 100 million (€ 13 million) seed fund targeted at startups in China. The company also officially opened its innovation hub in Shanghai and announced… 18 OCT 2019 | DARMSTADT, GERMANY RMB 100 million fund targets startups close to the three business sectors of Merck KGaA, Darmstadt, Germany, as well... Read more

September 4, 2019 Lab Top-10 PR/Corporate

David Alsteens Receives 2019 Heinrich Emanuel Merck Award for Analytical Science

04 SEP 2019 | DARMSTADT, GERMANY Belgian chemist wins prestigious science award worth € 15,000 Recognition of young researchers who develop new methods in chemical analysis Merck KGaA, Darmstadt, Germany, a leading science and technology company, presented Professor David Alsteens (33), Catholic University of Louvain (UCLovain), Louvain-la-Neuve, Belgium with the 2019 Heinrich Emanuel Merck Award for Analytical Science.... Read more

August 19, 2019 Licensing, IP, and Legal Life Science Tools Other Lab Products/Services

Merck KGaA, Darmstadt, Germany Granted 20 CRISPR Patents Total Worldwide

Merck KGaA, Darmstadt, Germany today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing its Life Science business’ patent… 19 AUG 2019 | DARMSTADT, GERMANY Patent offices in Europe, Israel, South Korea and U.K. issue seven additional grants for company’s CRISPR genome-editing technology Company has 20 allowed CRISPR patents... Read more

August 19, 2019 Lab Top-10 Licensing, IP, and Legal Life Science Tools

Merck KGaA, Darmstadt, Germany Granted 20 CRISPR Patents Total Worldwide

19 AUG 2019 | DARMSTADT, GERMANY Patent offices in Europe, Israel, South Korea and U.K. issue seven additional grants for company’s CRISPR genome-editing technology Company has 20 allowed CRISPR patents to date across nine different geographies Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the European, Israeli, South Korean and U.K. intellectual... Read more

July 18, 2019 Lab Top-10 Life Science Tools M&A, Partnerships

Merck KGaA, Darmstadt, Germany and Broad Institute Announce CRISPR License Framework to Encourage Innovation

18 JUL 2019 | DARMSTADT, GERMANY New framework simplifies and accelerates access to CRISPR intellectual property for research Merck KGaA, Darmstadt, Germany, a leading science and technology company, and the Broad Institute of MIT and Harvard today announced an agreement between Broad Institute and the Life Science business of Merck KGaA, Darmstadt, Germany to offer non-exclusive licenses... Read more

July 9, 2019 Lab Top-10 PR/Corporate

Future Insight Prize: € 1 Million Research Grant Awarded for the First Time

09 JUL 2019 | DARMSTADT, GERMANY Pardis Sabeti of Harvard University and the Broad Institute recognized for identifying innovative genetic technologies for detection and therapy of infectious diseases James Crowe of Vanderbilt University Medical Center recognized for uncovering mechanisms necessary for therapeutics and vaccines New research grant awarded in the category of a “Pandemic Protector” dream product... Read more

July 1, 2019 Industrial Lab Top-10 M&A, Partnerships

Merck KGaA, Darmstadt, Germany Places Bonds Amounting to € 2 Billion

01 JUL 2019 | DARMSTADT, GERMANY Issuance is final key component in the financing of the planned Versum transaction Three tranches placed Bonds significantly oversubscribed Darmstadt, Germany, July 1, 2019 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today successfully placed bonds amounting to € 2.0 billion. The placement is a component of the financing of... Read more

June 20, 2019 Lab Top-10 PR/Corporate

MilliporeSigma, EMD Serono and EMD Performance Materials make prestigious Massachusetts top employer list for 2019

20 JUN 2019 | BURLINGTON, MASSACHUSETTS, UNITED STATES OF AMERICA Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that its Massachusetts-based business sectors, MilliporeSigma, EMD Serono and EMD Performance Materials, have been named to the Boston Business Journal’s annual “Best Places to Work” list. Companies were selected based on survey responses provided by employees.... Read more

June 18, 2019 Industrial Lab Top-10 M&A, Partnerships PR/Corporate

Merck KGaA, Darmstadt, Germany, Places Hybrid Bond Amounting to € 1.5 billion

18 JUN 2019 | DARMSTADT, GERMANY Placement is an important part of the financing of the planned acquisition of Versum Materials, Inc. Tranches of € 1 billion and € 500 million placed Transaction significantly oversubscribed Merck KGaA, Darmstadt, Germany, a leading science and technology company, today successfully placed a hybrid bond amounting to € 1.5 billion. The... Read more